Mas...
En un comunicado de la compañía John Lechleiter, Ph.D, chief executive officer, informa que:"With each of our industry firsts, from launching our clinical trials registry to the public reporting of educational grants, Lilly is striving to be a leader in improving transparency across our industry,"
"As Lilly continues to look for more ways to be open and transparent about our business, we've learned that letting people see for themselves what we're doing is the best way to build trust."
A pocos días del anuncio de Lilly la gente de Merck (comunicado) ha tomado la misma decisión.Mas...
En resumen, que adoptan la T de "transparencia" como bandera y que, en lo sucesivo, haran públicos todos sus pagos...
Entradas
No hay comentarios:
Publicar un comentario